Multiple atypical nevi: a cutaneous marker of germ cell tumors.
OBJECTIVE
This study assessed whether a specific association exists between atypical nevi and germ cell tumors (GCT).


METHODS
A prospective comparison was performed on a cohort of 129 unselected patients with GCT and a series of 153 healthy men. Three or more of the following criteria were required for diagnosis of multiple atypical nevi: greater than 5 mm in diameter; variegated color, often speckled black/brown, with irregularly distributed pigmentation; irregular outline or indistinct border; and at least three such lesions.


RESULTS
Prevalences for multiple atypical nevi in patients with GCT and in healthy controls were 37% and 15%, respectively (P < .01). Two patients with these lesions also had documented malignant melanoma. In contrast, 16% of patients with GCT had a history of testicular maldescent (the most common known risk factor), compared with 5% of healthy controls (P < .01).


CONCLUSIONS
Multiple atypical nevi occur with a statistically significant increased prevalence in patients with GCT as compared with healthy controls, and constitute one of the most common known clinical associations with this malignancy. These data may be of relevance for our understanding of the biology of GCT and of malignant melanoma, in the design of screening programs for testis cancer, and in the follow-up evaluation of patients with each of these disorders.
Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY 14263.
D
D
Raghavan
J R
JR
Zalcberg
J J
JJ
Grygiel
N
N
Teriana
K M
KM
Cox
W
W
McCarthy
M
M
Flynn
D000293:Adolescent; D000328:Adult; D014408:Biomarkers, Tumor; D015331:Cohort Studies; D006801:Humans; D008297:Male; D008545:Melanoma / Q000150:complications / Q000453:epidemiology; D008875:Middle Aged; D009373:Neoplasms, Germ Cell and Embryonal / Q000150:complications* / Q000453:epidemiology / Q000473:pathology; D009506:Nevus / Q000150:complications* / Q000453:epidemiology / Q000473:pathology; D015995:Prevalence; D011446:Prospective Studies; D012878:Skin Neoplasms / Q000150:complications* / Q000453:epidemiology
D014408:Biomarkers, Tumor